DRAK2 aggravates nonalcoholic fatty liver disease progression through SRSF6-associated RNA alternative splicing

ABSTRACT: Drak2 Regulates RNA Alternative Splicing by Suppressing SRPK1-SRSF6 Signaling Pathway

ORGANISM(S): Mus Musculus

SUBMITTER: Minjia Tan  

PROVIDER: PXD028609 | iProX | Fri Sep 17 00:00:00 BST 2021

REPOSITORIES: iProX